Previous Section | Index | Home Page |
Mr. Burstow: To ask the Secretary of State for Health pursuant to the answer of 11 July 2005, Official Report, column 716W, on anti-psychotic drugs, if she will break down each category by those aged (a) 50 to 64, (b) 65 to 74, (c) 75 years and over. [15548]
Jane Kennedy:
Table one shows the total number of suspected adverse drug reaction (ADR) reports received via the yellow card scheme from 1 January to 31 December for each of the last five years, for all anti-psychotic drugs, traditional anti-psychotics and atypical anti-psychotics.
11 Oct 2005 : Column 473W
Tables two and three show a breakdown by age groups 50 to 64, 65 to 74 and 75 years and over for traditional and atypical anti-psychotics respectively.
5064 years | 6574 years | 75 and over | |
---|---|---|---|
2000 | 11 | 13 | 12 |
2001 | 20 | 14 | 13 |
2002 | 16 | 10 | 12 |
2003 | 21 | 16 | 19 |
2004 | 13 | 11 | 7 |
5064 years | 6574 years | 75 and over | |
---|---|---|---|
2000 | 150 | 50 | 47 |
2001 | 226 | 51 | 61 |
2002 | 219 | 59 | 66 |
2003 | 311 | 75 | 84 |
2004 | 328 | 68 | 73 |
Age was not provided in 14 per cent.68 reportsfor traditional anti-psychotics and 5 per cent.348 reportsfor atypical anti-psychotics.
It is important to note that a report of an adverse drug reaction does not necessarily mean that it was caused by the drug. Many factors have to be taken into account in assessing causal relationships including temporal association, the possible contribution of concomitant medication and the underlying disease.
Mr. Amess: To ask the Secretary of State for Health what the average annual cost to public funds of maintaining a child in care has been in each of the last six years for which figures are available. [14268]
Maria Eagle: I have been asked to reply.
The average gross annual expenditure per looked after child (average includes those in foster care and those in children's homes) in England for the latest available six years is as follows:
£ | |
---|---|
199899 | (9)19,920 |
19992000 | 21,270 |
200001 | 26,100 |
200102 | 25,300 |
200203 | 29,100 |
200304 | 32,100 |
Dr. Evan Harris: To ask the Secretary of State for Health what products Chiron supplies to the NHS. [16344]
Jane Kennedy: Chiron has three divisions, which supply the following products to the national health service:
Mr. Kevan Jones: To ask the Secretary of State for Health which (a) primary care trusts, (b) hospital trusts and (c) strategic health authorities made representations to her Department about the impact of Alliance Medical providing diagnostic scanning services in the NHS on the utilization of existing diagnostic scanning capacity within the NHS. [11886]
Mr. Byrne [holding answer 12 July 2005]: This information could be provided only at disproportionate cost, as the Department has many routine operational discussions with the national health service relating to these services.
Mrs. Dorries: To ask the Secretary of State for Health how many people have (a) requested and (b) received an appointment to see a general practitioner within 48 hours in (i) the parliamentary constituency of Mid-Bedfordshire and (ii) the County of Bedfordshire in each year since 2000. [16628]
Ms Rosie Winterton: This information is not collected in the format requested and the information that is collected centrally cannot be disaggregated to practices as each practice is anonymised within the primary care access survey.
The latest information available, September 2005, shows that 100 per cent. of patients were offered a general practitioner consultation within two working days in each of the three primary care trusts that cover Bedfordshire (Bedford, Luton and Bedfordshire and Hertlands).
Mr. Baron: To ask the Secretary of State for Health what discussions she has had with the Healthcare Commission on the waiting time targets for prostate cancer patients. [15709]
Ms Rosie Winterton
[holding answer 10 October 2005]: I have had no discussions with the Healthcare Commission on the waiting times targets for prostate cancer. The national health service cancer plan sets out our strategy to reduce waiting times for cancer patients. There are two targets for cancer patients to be achieved from the end of December 2005, of a maximum 31 day wait from diagnosis of cancer to start of treatment and 62 days from urgent referral for suspected cancer to first treatment. Prostate cancer patients fall within these groups. Achievement of these targets will form part of the Healthcare Commission's assessment of existing targets for 200506.
11 Oct 2005 : Column 476W
Julia Goldsworthy: To ask the Secretary of State for Health (1) what percentage of paper for printed publications used by the Department in 200304 and 200405 was from recycled sources; and how much post-consumer waste this paper contained; [15460]
(2) what measures she has put in place to ensure that her Department meets the targets set by the Department for Environment, Food and Rural Affairs to ensure that all copying paper for printed publications brought by the Department is 60 per cent. recycled, of which a minimum is 75 per cent. post-consumer waste. [15462]
Jane Kennedy: For parliamentary work carried out by the Central Office of Information (COI), for example Command Papers, Acts and other departmental papers, the minimum recycled fibre content required is 75 per cent. for coated and 100 per cent. for uncoated papers, virgin fibre pulp being elemental chlorine free or preferably totally chlorine free. Mill broke is not included in the recycled fibre content. Applying the National Association of Paper Merchants definition for recycled content, the recycled fibre can include converter's waste, printer's waste and post consumer waste from homes and offices.
For all other printed publications produced in 200304 and 200405, the Department has no central record of paper source and content, and could not obtain these without incurring disproportionate cost. However, the selection of paper stock and its recycled and environmental properties currently rests with the COI.